N
Power Law company profile
NanoString Technologies
Biotech & Life Sciences · Seattle, United States · Founded 2003 · IPO 2013 Unicorn
Valuation
$154M
Market cap · 2026
Revenue
$127M
Latest reported FY
Global footprint
Where NanoString Technologies has talent and traffic
AI talent share
0.4%
of workforce is AI talent
(1 of 235 staff)
(1 of 235 staff)
Core AI00%
Other AI10.43%
Non-AI workforce23499.57%
Web traffic by country
48K
monthly visits
across markets
across markets
🇺🇸 United States67.1%
🏳️ Korea6.9%
🏳️ Republic of4.2%
🇨🇦 Canada4.2%
🇬🇧 United Kingdom3.8%
Patent intelligence
$109M patent portfolio · 36 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$109M
70.7% of market cap · 7.2× smaller than top peer BioNTech ($780M)
36 active patent families
Where NanoString Technologies innovates
Molecular biologyBioinformaticsNucleic acidAssayProtein
Above peer median on Legal, Market, Economic, Technology
Quality vs same-sector peers
NanoString Technologies on the five Patsnap quality dimensions
NanoString Technologies in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where NanoString Technologies concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across NanoString Technologies and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee NanoString Technologies on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.